{
  "@context": "http://id.who.int/icd/contexts/contextForLinearizationEntity.json",
  "@id": "http://id.who.int/icd/release/11/2024-01/mms/1947911830",
  "parent": [
    "http://id.who.int/icd/release/11/2024-01/mms/672063490"
  ],
  "browserUrl": "https://icd.who.int/browse/2024-01/mms/en#1947911830",
  "code": "MG52.02",
  "source": "http://id.who.int/icd/entity/1947911830",
  "classKind": "category",
  "title": {
    "@language": "en",
    "@value": "Extensively drug-resistant mycobacterium tuberculosis"
  },
  "definition": {
    "@language": "en",
    "@value": "Extensively drug-resistant tuberculous mycobacteria are resistant to at least four of the core anti-TB drugs. XDR-TB mycobacteria are resistant to the two most powerful anti-TB drugs, isoniazid and rifampicin, also known as multidrug-resistance, in addition to resistance to any of the fluoroquinolones (such as levofloxacin or moxifloxacin) and to at least one of the three injectable second-line drugs (amikacin, capreomycin or kanamycin)."
  },
  "codingNote": {
    "@language": "en",
    "@value": "These categories should never be used in primary coding. The codes are provided for use as supplementary or additional codes when it is desired to identify the resistance, non-responsiveness and refractive properties of a condition to antimicrobials."
  },
  "indexTerm": [
    {
      "label": {
        "@language": "en",
        "@value": "Extensively drug-resistant mycobacterium tuberculosis"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "extensively drug-resistant tuberculous mycobacterium"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "XDR tuberculous mycobacterium - [Extensively drug-resistant] tuberculous mycobacterium"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "XDR TB - [extensively drug-resistant tuberculosis]"
      }
    }
  ]
}